Bright Green (BGXX) & Its Rivals Financial Review

Posted by on Jun 17th, 2023

Bright Green (NASDAQ:BGXX – Get Rating) is one of 56 public companies in the “Medicinals & botanicals” industry, but how does it contrast to its competitors? We will compare Bright Green to similar businesses based on the strength of its dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Bright Green and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bright Green 0 0 0 0 N/A
Bright Green Competitors 215 532 793 40 2.42

As a group, “Medicinals & botanicals” companies have a potential upside of 288.00%. Given Bright Green’s competitors higher probable upside, analysts clearly believe Bright Green has less favorable growth aspects than its competitors.

Institutional and Insider Ownership

8.5% of Bright Green shares are owned by institutional investors. Comparatively, 13.0% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 56.4% of Bright Green shares are owned by insiders. Comparatively, 22.4% of shares of all “Medicinals & botanicals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Bright Green and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bright Green N/A -278.60% -158.02%
Bright Green Competitors -11.76% -75.96% 22.27%

Valuation & Earnings

This table compares Bright Green and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Bright Green N/A -$27.66 million -4.88
Bright Green Competitors $266.63 million -$114.66 million -2.24

Bright Green’s competitors have higher revenue, but lower earnings than Bright Green. Bright Green is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Bright Green competitors beat Bright Green on 6 of the 9 factors compared.

Bright Green Company Profile

(Get Rating)

Bright Green Corporation focuses on the cultivation, manufacture, and sale of cannabis and cannabis-related products. Its products are used in research, pharmaceutical applications, and affiliated exports. The company was incorporated in 2019 and is based in Grants, New Mexico.

Receive News & Ratings for Bright Green Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Green and related companies with MarketBeat.com's FREE daily email newsletter.